Purchase Order 36C24725P0093

Award Date 10/16/24
Potential Completion Date 4/8/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune system, a cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) for the delivery of Optune medical devices, transducer arrays, rental...
This federal contract award is for the procurement of Optune Plus transducers from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm-fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc. as the prime contractor. The contract has an ultimate completion date of March 28, 2025 and does not utilize any set-aside designations. Novocure...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the delivery of the Optune Plus Transducers system to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $33,165.82 and is structured as a firm fixed-price delivery order, running through June 30, 2025. Novocure, acting as the prime contractor, will provide the Optune medical devices, transducer arrays, rental equipment,...
This federal contract award, valued at $16,582.91, was made by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of Optune Plus Transducers, which are part of Novocure's Optune system - an innovative cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. This contract does not have a set-aside...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. This contract does not utilize a set-aside designation, likely due to the...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducer devices and associated support services. The $33,165.82 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022. This contract enables the VA to efficiently...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This contract does not utilize any set-aside designations and is being...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a $16,582.91 firm-fixed-price delivery order issued under Novocure's $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA. The order is for Novocure's Optune Plus transducers, device rentals, and related support services for the treatment of glioblastoma and...

This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune Transducers, which are part of Novocure's Optune system - an innovative cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division.

The contract is a firm fixed-price purchase order, with an ultimate completion date of April 8, 2025. It does not have a set-aside designation. Novocure is the prime contractor, and the contract is issued under the company's existing Federal Supply Schedule (FSS) contract with the VA VHA, valued at $28.85 million and running through October 2027. This FSS contract serves as the primary procurement vehicle for the VA to obtain Novocure's Optune medical devices, transducer arrays, rental equipment, and associated support services to provide advanced, non-invasive cancer treatment options to veterans across the nation.

Generated 4/17/25, 8:50 AM